Pink Sheet Analysis Spotlights COVID-19 Article Debacle
June 12, 2020
A recent analysis by the Pink Sheet looks at how the retraction of Lancet and New England Journal of Medicine studies do not compromise opinions on the utility of real-world evidence for drug efficacy and safety.
Experts suggest the retractions, according to the analysis, stress the vital role of transparency and validation for real-world data.
To read the full analysis on The Pink Sheet, click here. (Paid subscription required)